View of Optimization of Treatment Based on JAK-STAT Signaling Pathway: Comparison of the Efficacy of Iguratimod Combined Therapy and Biological Agents in the Reconstruction of Immune Function in RA Patients

Return to Article Details Optimization of Treatment Based on JAK-STAT Signaling Pathway: Comparison of the Efficacy of Iguratimod Combined Therapy and Biological Agents in the Reconstruction of Immune Function in RA Patients Download Download PDF